{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T21:53:56Z","timestamp":1790373236606,"version":"4.1.0"},"reference-count":27,"publisher":"Informa UK Limited","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Chemotherapy"],"published-print":{"date-parts":[[2003,1]]},"DOI":"10.1179\/joc.2003.15.2.184","type":"journal-article","created":{"date-parts":[[2014,1,9]],"date-time":"2014-01-09T18:05:37Z","timestamp":1389290737000},"page":"184-191","source":"Crossref","is-referenced-by-count":13,"title":["Randomized, Controlled, Multicenter Phase III Trial of Standard-Dose Fluorouracil-Epirubicin- Cyclophosphamide (FEC), Compared with Time-Intensive FEC (FEC-G) and Mitoxantrone-Methotrexate-Mitomycin C (MMM-G) in Metastatic Breast Carcinoma"],"prefix":"10.1080","volume":"15","author":[{"given":"A.M.","family":"Capotorto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Pavesi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Pedrazzoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.A. Da","family":"Prada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Zamagni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Massidda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Farris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Martoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Lelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G. Robustelli Della","family":"Cuna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2013,7,18]]},"reference":[{"key":"CIT0001","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1987.226"},{"issue":"9","key":"CIT0002","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1200\/JCO.1991.9.2.295","volume":"1","author":"Habeshaw T","year":"1991","journal-title":"J Clin Oncol"},{"key":"CIT0003","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199405053301801"},{"key":"CIT0004","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1200\/JCO.1984.2.11.1281","volume":"4","author":"Hryniuk W","year":"1984","journal-title":"J Clin Oncol"},{"key":"CIT0005","first-page":"8","volume":"1997","author":"Biganzoli L","journal-title":"or what we know and what we still need to learn about anthracycline dose per course, dose density and cumulative dose in the treatment of breast cancer. Ann Oncol"},{"key":"CIT0006","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1200\/JCO.1988.6.9.1365","volume":"6","author":"Hryniuk WM","year":"1988","journal-title":"J Clin Oncol"},{"key":"CIT0007","first-page":"1160","volume":"50","author":"FMJr Schabel","year":"1980","journal-title":"Cancer"},{"key":"CIT0008","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1200\/JCO.1988.6.9.1377","volume":"6","author":"Tannock IF","year":"1998","journal-title":"J Clin Oncol"},{"key":"CIT0009","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1200\/JCO.1993.11.7.1253","volume":"11","author":"Focan C","year":"1993","journal-title":"J Clin Oncol"},{"key":"CIT0011","first-page":"155","volume":"8","author":"Brufman G","year":"1997","journal-title":"An interna-tional randomised phase III study in metastatic breast cancer. Ann Oncol"},{"issue":"1","key":"CIT0012","first-page":"10","volume":"21","author":"Marschner N","year":"1994","journal-title":"Semin Oncol"},{"key":"CIT0013","first-page":"1146","volume":"14","author":"Bastholt L","year":"1996","journal-title":"Dose-response relationship of epirubicin in the treatment of postmenopausal patients with metastatic breast cancer: a randomized study of epirubicin at four different dose levels performed by Danish Breast Cancer Cooperative Group. J Clin Oncol"},{"key":"CIT0014","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1023\/A:1008270307264","volume":"8","author":"Fountzilas G","year":"1997","journal-title":"Ann Oncol"},{"key":"CIT0015","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-199549050-00009"},{"key":"CIT0016","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-200059030-00017"},{"key":"CIT0017","doi-asserted-by":"crossref","first-page":"289","DOI":"10.3109\/10428199709114168","volume":"25","author":"Gisselbrecht C","year":"1997","journal-title":"Leuk Lymphoma"},{"key":"CIT0019","first-page":"2001","author":"NCSS Hintze J.","year":"2001","journal-title":"Rel"},{"key":"CIT0020","first-page":"185","volume":"35","author":"Peto R","year":"1972","journal-title":"J R Stat Soc"},{"key":"CIT0021","doi-asserted-by":"publisher","DOI":"10.2307\/2530927"},{"key":"CIT0022","unstructured":"Agresti A. Categorical Data Analysis. John Wiley & Sons, New York, 1990."},{"key":"CIT0023","doi-asserted-by":"publisher","DOI":"10.1080\/01621459.1958.10501452"},{"key":"CIT0024","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.2517-6161.1972.tb00899.x","volume":"34","author":"Cox DR","year":"1972","journal-title":"J R Stat Soc"},{"key":"CIT0025","first-page":"121","volume":"1","author":"Hryniuk WM","year":"1988","journal-title":"Important Adv Oncol"},{"key":"CIT0026","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19810101)47:1<207::AID-CNCR2820470134>3.0.CO;2-6"},{"key":"CIT0027","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200004133421501"},{"key":"CIT0028","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.1200\/JCO.1997.15.8.2981","volume":"15","author":"Savarese DMF","year":"1997","journal-title":"J Clin Oncol"},{"key":"CIT0029","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1200\/JCO.2001.19.8.2213","volume":"19","author":"Del Mastro L","year":"2001","journal-title":"J Clin Oncol"}],"container-title":["Journal of Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/10256018808623883","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,22]],"date-time":"2024-05-22T21:59:53Z","timestamp":1716415193000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.tandfonline.com\/doi\/full\/10.1179\/joc.2003.15.2.184"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,1]]},"references-count":27,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2013,7,18]]},"published-print":{"date-parts":[[2003,1]]}},"alternative-id":["10.1179\/joc.2003.15.2.184"],"URL":"https:\/\/doi.org\/10.1179\/joc.2003.15.2.184","relation":{},"ISSN":["1120-009X","1973-9478"],"issn-type":[{"value":"1120-009X","type":"print"},{"value":"1973-9478","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,1]]}}}